Even if the expression pattern of AKR1C1 and C2 is influenced by the cancer state (primary PCa vs. advanced CRPCa), the molecular mechanism behind this difference has not yet been elucidated [30]. The gene discussed is AKR1C1; the disease is posterior cortical atrophy.